How much is Navigator Medicines worth in 2026?

Navigator Medicines has a current valuation of N/A based on their Early Stage VC (Series A) round and secondary market data.

How much funding has Navigator Medicines raised?

Navigator Medicines has raised N/A in total funding across 1 funding rounds.

Navigator Medicines

Drug Discovery

Navigator Medicines valuation and funding history | Last updated: August 23, 2024 | 1 funding rounds

Current Valuation

N/A

As of August 23, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

Early Stage VC (Series A)

$100.0M

Last Funding

Aug 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
August 23, 2024	Early Stage VC (Series A)	$100.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Navigator Medicines is currently valued at N/A as of August 23, 2024.

Track Navigator Medicines Valuation Updates

Get notified when Navigator Medicines raises new funding or valuation changes

Explore More Data

Detailed analysis for Navigator Medicines

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Navigator Medicines's valuation history, funding rounds, and growth metrics.

No credit card required

What is Navigator Medicines Worth in 2026?

Navigator Medicines is a leading private company in the Drug Discovery sector. Track Navigator Medicines's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Navigator Medicines Valuation is Determined

Private company valuations like Navigator Medicines's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.